nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex
|
Tomioka, Haruaki |
|
2002 |
19 |
2 |
p. 139-145 7 p. |
artikel |
2 |
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998–1999) including an in vitro evaluation of BMS284756
|
Bell, J.M. |
|
2002 |
19 |
2 |
p. 125-132 8 p. |
artikel |
3 |
Apparent plateau in β-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative
|
Jones, Mark E. |
|
2002 |
19 |
2 |
p. 119-123 5 p. |
artikel |
4 |
Classification of oral cephalosporins
|
Shah, Pramod M |
|
2002 |
19 |
2 |
p. 163-164 2 p. |
artikel |
5 |
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients
|
Di Bonaventura, Giovanni |
|
2002 |
19 |
2 |
p. 147-154 8 p. |
artikel |
6 |
Erratum to letter “Mupirocin resistance in Staphyloccus aureus from Greek hospitals”
|
Tzouvelekis, L.S. |
|
2002 |
19 |
2 |
p. 165- 1 p. |
artikel |
7 |
Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line
|
Lazarev, V.N |
|
2002 |
19 |
2 |
p. 133-137 5 p. |
artikel |
8 |
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates
|
Speciale, A |
|
2002 |
19 |
2 |
p. 111-118 8 p. |
artikel |
9 |
Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients
|
Kitzes-Cohen, Ruth |
|
2002 |
19 |
2 |
p. 105-110 6 p. |
artikel |
10 |
Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections
|
Naber, Kurt G. |
|
2002 |
19 |
2 |
p. 95-103 9 p. |
artikel |
11 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon
|
Sharara, Ala I |
|
2002 |
19 |
2 |
p. 155-158 4 p. |
artikel |
12 |
The burden of invasive pneumococcal disease and the potential for reduction by immunisation
|
Parsons, Helena K. |
|
2002 |
19 |
2 |
p. 85-93 9 p. |
artikel |
13 |
Use of Etests with carbapenems for Gram-negative rods producing β-lactamases
|
Kocazeybek, Bekir S. |
|
2002 |
19 |
2 |
p. 159-162 4 p. |
artikel |